Clinical outcomes and risk factors of Acinetobacter baumannii meningitis in pediatric patients at a tertiary hospital in China

Front Cell Infect Microbiol. 2024 Aug 29:14:1408959. doi: 10.3389/fcimb.2024.1408959. eCollection 2024.

Abstract

Objectives: To summarize the clinical characteristics, outcomes and identify risk factors of Acinetobacter baumannii (AB) meningitis in children.

Methods: This was a single-center, retrospective study. Children hospitalized between January 2016 and December 2021 who were diagnosed with AB meningitis were included. The clinical characteristics and outcomes were reviewed. Risk factors were determined using univariate analyses (chi-square and Mann-Whitney U tests).

Results: Seventeen patients were included; 15 cases were secondary to neurosurgery, and two were neonates with primary bacterial meningitis. Common symptoms included fever, convulsions and nervous system abnormalities. Cerebrospinal fluid (CSF) tests typically showed increased white blood cell counts dominated by neutrophils, reduced glucose levels and elevated protein levels. Ten patients were successfully treated (successful treatment [ST] group); seven had failed treatment (failed treatment [FT] group). Univariate analyses revealed that mechanical ventilation, routine white cell counts in the peripheral blood, procalcitonin, protein in the CSF, septic shock and carbapenem-resistant AB (CRAB) differed significantly between the groups.

Conclusion: AB meningitis in children has a high mortality rate. FT was associated with mechanical ventilation, septic shock, CRAB, lower peripheral leukocyte counts, higher protein levels in the CSF and procalcitonin. Larger studies are needed to identify independent risk factors for adverse outcomes.

Keywords: Acinetobacter baumannii; carbapenem-resistant; children; clinical characteristics; meningitis; outcomes.

MeSH terms

  • Acinetobacter Infections* / microbiology
  • Acinetobacter baumannii*
  • Adolescent
  • Anti-Bacterial Agents* / therapeutic use
  • Carbapenems / therapeutic use
  • Child
  • Child, Preschool
  • China / epidemiology
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Leukocyte Count
  • Male
  • Meningitis, Bacterial* / microbiology
  • Meningitis, Bacterial* / mortality
  • Retrospective Studies
  • Risk Factors
  • Tertiary Care Centers*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Carbapenems

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.